Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - DoubtfulReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Current Assets: 2010-2025

Historic Current Assets for Exponent (EXPO) over the last 15 years, with Oct 2025 value amounting to $416.8 million.

  • Exponent's Current Assets rose 1.02% to $416.8 million in Q4 2025 from the same period last year, while for Oct 2025 it was $416.8 million, marking a year-over-year increase of 1.02%. This contributed to the annual value of $446.9 million for FY2025, which is 17.75% up from last year.
  • As of Q4 2025, Exponent's Current Assets stood at $416.8 million, which was down 2.08% from $425.7 million recorded in Q3 2025.
  • Exponent's Current Assets' 5-year high stood at $452.8 million during Q4 2021, with a 5-year trough of $318.3 million in Q1 2023.
  • Its 3-year average for Current Assets is $387.6 million, with a median of $391.3 million in 2024.
  • Its Current Assets has fluctuated over the past 5 years, first climbed by 27.05% in 2021, then declined by 22.88% in 2022.
  • Over the past 5 years, Exponent's Current Assets (Quarterly) stood at $452.8 million in 2021, then declined by 22.88% to $349.2 million in 2022, then grew by 8.70% to $379.5 million in 2023, then increased by 20.18% to $412.6 million in 2024, then grew by 1.02% to $416.8 million in 2025.
  • Its Current Assets was $416.8 million in Q4 2025, compared to $425.7 million in Q3 2025 and $432.8 million in Q2 2025.